Imidazoline receptors, non-adrenergic idazoxan binding sites and α2-adrenoceptors in the human central nervous system
References (38)
A rapid and sensitive method for the quantitation of protein utilizing the principle protein-dye binding
Anal. Biochem.
(1976)- et al.
Evidence for the existence of a homogenous population of imidazoline receptors in the human brainstem
Eur. J. Pharmac.
(1988) - et al.
The imidazoline preferring receptor: binding studies in bovine, rat and human brainstem
Eur. J. Pharmac.
(1989) - et al.
Heterogeneity of the specific imidazoline binding of [3H]idazoxan in the human cerebral cortex
Neurochem. Int.
(1993) - et al.
High affinity binding of [3H]rauwolscine and [3H]RX781094 to α2 adrenergic receptors and non-stereoselective sites in human and rabbit brain cortex membranes
Biochem. Pharmac.
(1989) - et al.
[3H]Rauwolscine labels α2 adrenoceptors and 5-HT1A receptors in human cerebral cortex
Eur. J. Pharmac.
(1989) - et al.
Evidence for imidazoline binding sites in basolateral membranes from rabbit kidney
Biochem. Biophys. Res. Commun.
(1987) - et al.
Autoradiographic distribution of α2 adrenoceptors, NAIBS and 5-HT1A receptors in human brain using [3H]idazoxan and [3H]rauwolscine
Brain Res.
(1991) - et al.
α adrenergic neurons tonically inhibit sympathoexcitatory neurons of the Cl area in brainstem
Brain Res.
(1986) - et al.
[3H]Idazoxan binding at non-alpha2-adrenoceptors in rabbit adipocyte membranes
Eur. J. Pharmac.
(1989)
[3H]RX821002: a new tool for identification of α2 adrenoceptors
Eur. J. Pharmac.
An endogenous clonidine-displacing substance from bovine brain: receptor binding and hypotensive actions in the ventrolateral medulla
Life Sci.
LIGAND: a versatile computerised approach for characterisation of ligand binding systems
Analyt. Biochem.
Quantitative light microscopic autoradiographic localisation of α2 adrenoceptors in the human brain
Brain Res.
Identification of an imidazoline/guanidinium receptive site in mitochondria from rabbit cerebral cortex
Eur. J. Pharmac.
Subcellular distribution of imidazoline/guanidinium receptive site in human and rabbit liver
J. Biol. Chem.
Selectivity of rilmenidine for the nucleus reticularis lateralis, a ventrolateral medullary structure containing imidazoline-preferring receptors
Eur. J. Pharmac.
Characterisation of alpha-adrenoceptors participating in the central hypotensive and sedative effects of clonidine using yohimbine, rauwolscine and corynanthine
Eur. J. Pharmac.
Identification of α2 adrenoceptors in human frontal cortex membranes by binding of [3H]RX821002, the 2-methoxy analog of [3H]idazoxan
Neurochem. Int.
Cited by (151)
New PET radiopharmaceuticals for imaging CNS diseases
2022, Nuclear Medicine and Molecular Imaging: Volume 1-4Possible involvement of agmatine in neuropharmacological actions of metformin in diabetic mice
2021, European Journal of PharmacologyInvolvement of agmatine in antidepressant-like effect of HMG-CoA reductase inhibitors in mice
2021, European Journal of PharmacologyDexmedetomidine and regional anaesthesia
2020, Praticien en Anesthesie ReanimationAgmatine reverses ethanol consumption in rats: Evidences for an interaction with imidazoline receptors
2019, Pharmacology Biochemistry and BehaviorCitation Excerpt :It exhibits anxiolytic (Taksande et al., 2014), anti-depressant (Taksande et al., 2009; Kotagale et al., 2013), anti-nociceptive (Aglawe et al., 2014), anti-convulsive (Bence et al., 2003; Feng et al., 2005), anti-inflammatory (Satriano et al., 2001; Taksande et al., 2017) and neuroprotective effects (Dixit et al., 2018). Agmatine is an endogenous ligand for imidazoline receptors (Reis and Regunathan, 1998; Raasch et al., 2001) and its anatomical distribution within the brain areas supports this correlation (De Vos et al., 1994; Raasch et al., 1995). Imidazoline receptors modulate several actions of ethanol, its intake and the development of dependence or withdrawal syndrome (Uzbay et al., 2000; Dobrydnjov et al., 2004; Lewis et al., 2007; Mao and Abdel-Rahman, 1996; Rommelspacher et al., 1991, 1996; Spies et al., 1996).
Molecular Imaging in Huntington's Disease
2018, International Review of Neurobiology